Developing targeted therapies to address heterogeneity in AML

(2:16)

Developing Targeted Therapeutics: What You Need to Know

(36:25)

Developing targeted radiotherapies to improve survival for people with relapsed or refractory AML

(5:45)

Developing targeted therapies for urachal and non-urachal adenocarcinoma

(1:7)

Developing targeted therapies to combine with venetoclax in acute myeloid leukemia (AML)

(1:33)

EP 166: Developing targeted therapies for ALS with Eric Green from Trace Neuroscience, Maze Thera...

(42:55)

Developing targeted therapies for AML: subgroups and trial design

(1:2)

EP 166: Developing targeted therapies for ALS with Eric Green from Trace Neuroscience

(44:42)

4 Ways to Develop Leadership Skills and Reduce Attrition by 50%

(3:)

Kinnate Biopharma Inc. - Developing Targeted Therapies for Those Battling Cancer

(10:17)

Developing a Targeted Learning-Based Statistical Analysis Plan

(52:59)

Developing targeted therapies for soft tissue sarcomas

(3:22)

Targets, Mechanism, and Disease: Biomarker Development

(2:46)

Developing Targeted Therapies to Address Resistance in Cancer

(29:35)

The Next CDx Frontier: Developing Targeted Therapies for Complex Neurological Diseases

(48:39)

Vivek Subbiah, MD, on developing targeted therapies for RET fusion + solid tumors and effectivity

(1:54)

The Bioverge Podcast: Developing Targeted Therapies to Address Heart Failure

(45:51)

Susan Faja, Ph.D.: Developing targeted interventions for autism spectrum disorders

(57:32)

Targeted protein degrader technology | A revolutionary approach to drug development

(42)

Developing targeted therapies for melanoma

(2:13)